Abstract
Introduction Optimizing the safety of obstetric patient care is a primary concern for many hospitals. Identifying performance indicators that measure aspects of patient care processes related to preventable harms can present opportunities to improve health systems.
In this paper, we present our protocol for a scoping review to identify performance indicators for obstetric safety. We aim to identify a comprehensive list of obstetric safety indicators which may help reduce the number of preventable patient harms, to summarize the data and to synthesize the results.
Methods and analysis We will use the methodological framework described by Arksey and O’ Malley and further expanded by Levac. We will search multiple electronic databases such as Medline, Embase, CINAHL and the Cochrane Library as well as websites from professional bodies and other organisations, using an iterative search strategy. We will include indicators that relate to preventable harms in the process of obstetric care.
Two reviewers will independently screen titles and abstracts of search results to determine eligibility for inclusion. For records where eligibility is not clear, the reviewers will screen the full text version. If reviewers’ decisions regarding eligibility differ, a third reviewer will review the full text record. Two reviewers will independently extract data from records that meet our inclusion criteria using a standardized data collection form. We will narratively describe quantitative data, such as the frequency with which indicators are identified, and conduct a thematic analysis of the qualitative data. We will compile a comprehensive list of patient safety indicators identified during our scoping review and organise them according to concepts that best suit the data such as the Donabedian model or the Hospital Harm Framework. We will discuss the implications of the indicators for future research, clinical practice and policy making.
We will report the conduct of the review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA ScR) Checklist.
Ethics and Dissemination The sources of information included in this scoping review will be available to the public. Therefore, ethical review for this research is not warranted. We will disseminate our research results using multiple modes of delivery such as a peer-reviewed publication, conference presentations and stakeholder communications.
Strengths and limitations of this study
We will use systematic methods to conduct and report this scoping review based on established methods introduced by Arksey and O’ Malley and further developed by Levac.
We will report the conduct of the review using guidance from the PRISMA Extension for Scoping Reviews (PRISMA-ScR).
We will limit the focus of this review to patient safety indicators from English language resources aimed at health system processes in developed countries.
We will not assess the risk of bias or certainty of the evidence in the included records because this is a scoping review to identify potential obstetrical safety indicators.
After the scoping review, we will present the identified indicators to key informants in a consensus process to create a shortlist that may not be suitable for inclusion in a future obstetrical safety dashboard for BORN (Better Outcomes Registry and Network) Ontario. BORN collects and safeguards data, and shares information to improve the delivery of maternal, neonatal and child healthcare across the province.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This scoping review was registered on the Open Science Framework on the 8th of November, 2019. Link: https://osf.io. DOI: 10.17605/OSF.IO/DJMQW
Funding Statement
Aislinn Conway is the recipient of a Health Systems Impact Fellowship co-funded by the Canadian Institutes of Health Research Institute of Health Services and Policy Research (CIHR-IHSPR) and the Children’s Hospital of Eastern Ontario (CHEO) Research Institute.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data will be made publicly available on the Open Science Framework or by request at: aislinnconway{at}gmail.com
